New studies highlight PBMs’ profit sources, customer dissatisfaction
As Congress, the U.S. Federal Trade Commission (FTC), and industry are taking a closer look at pharmacy benefit managers (PBMs)
ASCO: J&J, Legend’s Carvykti stages stellar show in earlier myeloma. But has the CAR-T reached a ceiling?
As Congress, the U.S. Federal Trade Commission (FTC), and industry are taking a closer look at pharmacy benefit managers (PBMs)
Moderna/Merck cancer vaccine plus Keytruda delays skin cancer return
As Congress, the U.S. Federal Trade Commission (FTC), and industry are taking a closer look at pharmacy benefit managers (PBMs)
Monthly Injections Might Lower Bleeding in People With Hemophilia
As Congress, the U.S. Federal Trade Commission (FTC), and industry are taking a closer look at pharmacy benefit managers (PBMs)
TECH Radioligand therapy, a ‘game-changer’ for cancer treatment, forces manufacturers to race against a ticking clock
As Congress, the U.S. Federal Trade Commission (FTC), and industry are taking a closer look at pharmacy benefit managers (PBMs)
Top 10 most anticipated drug launches of 2023
As Congress, the U.S. Federal Trade Commission (FTC), and industry are taking a closer look at pharmacy benefit managers (PBMs)
Pfizer’s hemophilia B gene therapy is better than standard of care in phase 3 trial
As Congress, the U.S. Federal Trade Commission (FTC), and industry are taking a closer look at pharmacy benefit managers (PBMs)
